During the past decade, Contact Alcon for Trial Locations conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Contact Alcon for Trial Locations" are "Cataract" (2 trials) and "Bacterial Conjunctivitis" (1 trials). Many other conditions were trialed in "Contact Alcon for Trial Locations" in a lesser frequency.

Most popular intervention types in "Contact Alcon for Trial Locations" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BSS Plus" (1 trials), "Ketorolac Tromethamine ophthalmic solution 0.4%" (1 trials), "Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%" (1 trials), "Moxifloxacin hydrochloride ophthalmic solution 0.5% as base" (1 trials) and "Nepafenac ophthalmic solution 0.1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Contact Alcon for Trial Locations" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Contact Alcon for Trial Locations". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Contact Alcon for Trial Locations, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Contact Alcon for Trial Locations, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".